Delivery Order 36F79720D0148-36C24524N0928

Award Date 9/19/24
Potential Completion Date 9/27/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Harmony Biosciences LLC is a $10,170 firm-fixed-price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration. The award is placed against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The delivery order is for WAKIX 17.8 MG, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The...
This federal contract award was made by the Veterans Health Administration, a component of the U.S. Department of Veterans Affairs, to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The contract is a delivery order with a firm fixed price of $10,418.14 and a completion date of August 22, 2025. It is part of a larger Blanket Purchase Agreement (BPA) valued at $25,000,000 and an Indefinite-Delivery Indefinite-Quantity (IDIQ)...
This federal contract award is a delivery order valued at $656,342.82 issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The award is for the bulk order of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. Harmony...
This federal contract award is for the delivery of WAKIX 17.8 MG tablets to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5. The $10,418.14 firm fixed price delivery order was awarded to Harmony Biosciences LLC, a for-profit pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The contract is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and supports...
This is a federal contract award to Harmony Biosciences LLC, a pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The contract has an award ceiling value of $10,418.14 and is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the Department of Veterans Affairs (VA). The contract is for the provision of WAKIX 17.8 mg tablets, which are used to treat excessive daytime sleepiness and cataplexy in adult...
The U.S. Department of Veterans Affairs (VA) awarded a $10,170 firm-fixed-price delivery order to Harmony Biosciences LLC for the pharmaceutical drug WAKIX 17.8MG 60 DOSES. This order is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. Harmony Biosciences is a for-profit pharmaceutical company that specializes in rare neurological diseases and sleep disorders. The delivery order has a period of...
This federal contract award is a delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The contract, valued at $5,209.07, is for the supply of WAKIX (pitolisant) 17.8 mg tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The contract, valued at $10,418.14, is for the delivery of WAKIX 17.8 mg tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued under Harmony Biosciences' Federal Supply Schedule (FSS-61-IB) for...
The U.S. Department of Veterans Affairs (VA) awarded a $5,085.12 firm fixed price delivery order to Harmony Biosciences LLC, a pharmaceutical manufacturer, to provide WAKIX 17.8 MG tablets. This order is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The delivery order has a completion date of September 27, 2024. No set-aside designation was applied to this procurement. Harmony...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The contract, valued at $20,340, is for the supply of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract was placed against Harmony Biosciences' General...

This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The $10,170 firm-fixed-price delivery order is for WAKIX 17.8 MG, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients.

The contract is issued against Harmony Biosciences' General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of September 27, 2024. Harmony Biosciences also holds a $5 million Blanket Purchase Agreement and a $259,000 multiple award indefinite-delivery indefinite-quantity (IDIQ) contract with the VA to provide WAKIX and other drugs through the GSA schedule. No set-aside provisions were used for this pharmaceutical procurement.

Generated 9/20/24, 9:30 AM